Noom’s Billion Dollar Valuation: The Missing Clinical Validation
The promise of AI in health is immense, yet the path to realizing its full potential is riddled with critical questions of safety, validation, and…
Hims & Hers: Billion Dollar Growth, Patient Safety Scrutiny
The burgeoning digital health market, exemplified by companies like Hims & Hers Health, presents a compelling paradox: exponential revenue growth alongside persistent questions regarding the…
Forward Health’s Fall: When Tech-First Ignores Clinical Validation
The November 2024 shutdown of Forward Health, a venture-backed primary care provider, after raising a staggering $650 million, sends a chilling message to both investors…
Pulse Oximeter Bias: A 30-Year Failure in Cardiac AI
The stark reality of algorithmic bias in healthcare is perhaps nowhere more tragically evident than in the case of pulse oximeters. Imagine a device, ubiquitous…
AI’s Billion-Dollar Blind Spot: The Algorithm That Failed 200M Patients
The promise of artificial intelligence in healthcare is vast, yet its deployment without rigorous scrutiny carries profound risks. A stark illustration of this danger emerged…
Teladoc’s 13 Billion Dollar Blunder: Integration Failure Lessons
The digital health landscape is littered with cautionary tales, but few resonate with the stark financial and clinical implications of Teladoc Health’s acquisition of Livongo.…
Racial Bias in AI: A Billion-Dollar Healthcare Blindspot
The promise of artificial intelligence in healthcare is vast, offering unprecedented opportunities for precision, efficiency, and improved patient outcomes. Yet, as with any powerful technology,…
Olive AI’s Billion Dollar Bust: The Evidence-Free Fall of a Health AI Unicorn
The story of Olive AI is a cautionary tale for investors and health system CIOs navigating the burgeoning landscape of healthcare AI. Once heralded as…
AI in ED: Missed Diagnoses & Delayed Treatment Risks
The integration of artificial intelligence into emergency departments promised a revolution in diagnostic speed and treatment initiation, yet growing evidence suggests a more complex reality.…
Babylon Health’s $4.2 Billion Collapse: A Clinical Accuracy Post-Mortem
The search results confirm that Babylon Health’s US branch filed for Chapter 7 bankruptcy in August 2023, and its British branch entered administration in September…